welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
- Ostomy Nutrition GuideThis handout is designed to help answer...
- Ileal Pouch-Anal Anastomosis RegistryLittle is known about the factors that p...
- Role of Surgery in Familial Adenomatous Polyposis and Hereditary Non Polyposis Colorectal Cancer (Lynch Syndrome)Surgery remains the mainstay of treatmen...
- Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous PolyposisA Phase 2, randomized, double blind, pla...
- Label-Free Global Serum Proteomic Profiling Reveals Novel Celecoxib-Modulated Proteins in Familial Adenomatous Polyp...Celecoxib, a selective inhibitor of cycl...
- Laparoscopic Colectomy and Restorative Proctocolectomy for Familial Adenomatous PolyposisBACKGROUND : Familial adenomatous polypo...